Loading...

BHC BAUSCH HEALTH COMPANIES INC Company Mergers 8-K Filing

BSCH

BHC

BAUSCH HEALTH COMPANIES INC

(BHC)

2025 8-K

Debt Refinancing Update

Debt Exchange Results

Quarterly Results

Shareholder Approval

Bausch Merger Success

Director Changes

Financial Statements

Debt Restructuring

Debt Restructuring

Financial Statements

Shareholder Rights Plan

Financial Results

Q3 Earnings Report

Financial Results Announcement

Appointment of CFO

Annual Meeting of Shareholders

Financial Results Announcement

Financial Results Announcement

Departure of Directors

Acquisition of XIIDRA and o...

Financial Results Announcement

Secured Notes Offering

Resignation of CFO

Acquisition Financing

Acquisition of XIIDRA and o...

Financial Results Announcement

Acquisition of XIIDRA and o...

Annual Meeting of Shareholders

Financial Results Announcement

External Links:

On September 11, 2025, Bausch Health Companies Inc. successfully completed its tender offer for DURECT Corporation, acquiring approximately 62% of shares at $1.75 each, plus contingent rights worth up to $350 million. The transaction culminated in DURECT becoming a wholly-owned subsidiary of Bausch Health.

AI Assistant

BAUSCH HEALTH COMPANIES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.